Clover Biopharmaceuticals Ltd(2197) News

Date	Title
Dec 28	Clover Announces Positive Phase Ⅰ Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)
Nov 7	Clover Completes BLA Submission for Seasonal Influenza Vaccine in Brazil